Monitoring primary breast cancer throughout chemotherapy using FDG-PET

Garry M McDermott, Andrew Welch, Roger T Staff, Fiona J Gilbert, Lutz Schweiger, Scott I K Semple, Tim A D Smith, Andrew W Hutcheon, Iain D Miller, Ian C Smith, Steven D Heys

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

We have compared 2-deoxy-2-[(18)F]-fluoro-D-glucose positron emission tomography (FDG-PET) images of large or locally advanced breast cancers (LABC) acquired during Anthracycline-based chemotherapy. The purpose was to determine whether there is an optimal method for defining tumour volume and an optimal imaging time for predicting pathologic chemotherapy response.
Original languageEnglish
Pages (from-to)75-84
Number of pages10
JournalBreast cancer research and treatment
Volume102
Issue number1
DOIs
Publication statusPublished - 2007

Fingerprint

Dive into the research topics of 'Monitoring primary breast cancer throughout chemotherapy using FDG-PET'. Together they form a unique fingerprint.

Cite this